Olmesartan Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome by Suppressing Tubular Expression of TGFβ.

MLA

Suh, Sang Heon, et al. “Olmesartan Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome by Suppressing Tubular Expression of TGFβ.” International Journal of Molecular Sciences, vol. 20, no. 15, Aug. 2019. EBSCOhost, https://doi.org/10.3390/ijms20153843.

APA

Suh, S. H., Choi, H. S., Kim, C. S., Kim, I. J., Ma, S. K., Scholey, J. W., Kim, S. W., & Bae, E. H. (2019). Olmesartan Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome by Suppressing Tubular Expression of TGFβ. International Journal of Molecular Sciences, 20(15). https://doi.org/10.3390/ijms20153843

Chicago

Suh, Sang Heon, Hong Sang Choi, Chang Seong Kim, In Jin Kim, Seong Kwon Ma, James W Scholey, Soo Wan Kim, and Eun Hui Bae. 2019. “Olmesartan Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome by Suppressing Tubular Expression of TGFβ.” International Journal of Molecular Sciences 20 (15). doi:10.3390/ijms20153843.